Is Ammonium chloride + Diphenhydramine + Sodium citrate registered with the SFDA?

The SFDA human drug list (edition 4-2026, as published by the Council of Health Insurance) lists 1 valid registration of Ammonium chloride + Diphenhydramine + Sodium citrate, including AMYDRAMINE EXPECTORANT SYRUP (2.7,11.4,26.3 mg/ml,mg/ml,mg/ml, Syrup, SAR 8.30).

Active substances

Ammonium chloride + Diphenhydramine + Sodium citrate

SFDA 2

Open in the medicines table

SFDA Saudi Arabia — SFDA human drug list

Trade name	Strength	Form · route	Pack	Public price	Type	Company	Status
AMYDRAMINE EXPECTORANT SYRUP	2.7,11.4,26.3 mg/ml,mg/ml,mg/ml	Syrup · Oral use	1 Bottle	SAR 8.30	Generic · OTC	Gulf Pharmaceutical Industries (Julphar)	Valid
KOFFEX SYRUP FOR ADULT	12.5,50,24 mg,mg,mg	Syrup · Oral use	1 Bottle	SAR 9.35	NCE · OTC	XELLIA PHARMACEUTICAL APS	Withdrawn by MAH · Not Marketed

Indications — CHI Daman Drug Formulary

BACTERIAL TONSILLOPHARYNGITIS TREATMENT AND PREVENTION; RENAL TRANSPLANT

Components

Diphenhydramine

Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.